LogoLogoLogoLogo
  • Team
  • Investors & Media
  • Government
    • Policies
  • Contact
  • Team
  • Investors & Media
  • Government
    • Policies
  • Contact
Synaptogenix | Press Release
261
archive,paged,category,category-press-release,category-261,paged-2,category-paged-2,wp-theme-stockholm,ajax_fade,page_not_loaded,,select-theme-ver-4.4,wpb-js-composer js-comp-ver-5.4.7,vc_responsive
April 1, 2014 In Press Release

Neurotrope, Inc., Appoints James Gottlieb to the Company’s Board of Directors

...

January 28, 2014 In Press Release

Neurotrope, Inc., Hires Three Experienced Senior Pharmaceutical Executives – A Chief Medical Officer and Heads of Commercial Operations and Regulatory Affairs

...

January 14, 2014 In Press Release

Neurotrope, Inc., to Present at Noble Financial Tenth Annual Equity Conference in Sandpiper, Florida

...

January 6, 2014 In Press Release

Neurotrope, Inc., to Present at Biotech Showcase 2014 in San Francisco

...

October 22, 2013 In Press Release

Neurotrope, Inc., Appoints Paul E. Freiman to the Company’s Board of Directors

...

October 15, 2013 In Press Release

Neurotrope, Inc., Announces Dr. Larry D. Altstiel, M.D., Ph.D. Appointed to the Company’s Scientific Advisory Board

...

October 9, 2013 In Press Release

Neurotrope, Inc., Announces Closing of Additional $1.08 Million of its Private Offering

...

October 7, 2013 In Press Release

Neurotrope, Inc., Announces Hiring Robert Weinstein As Executive Vice President and Chief Financial Officer

...

August 29, 2013 In Press Release

Neurotrope, Inc., Announces Reverse Merger and Completion of $21.9 Million Private Offering

...

  • 1
  • 2